PERSPECTIVE – A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment

January 29, 2020 at 8:30 am

New England J of Medicine January 24, 2020

V.J. Munster and Others

novel coronavirus, designated as 2019-nCoV, emerged in Wuhan, China, at the end of 2019. As of January 24, 2020, at least 830 cases had been diagnosed in nine countries: China, Thailand, Japan, South Korea, Singapore, Vietnam, Taiwan, Nepal, and the United States. Twenty-six fatalities occurred, mainly in patients who had serious underlying illness.1 Although many details of the emergence of this virus — such as its origin and its ability to spread among humans — remain unknown, an increasing number of cases appear to have resulted from human-to-human transmission. Given the severe acute respiratory syndrome coronavirus (SARS-CoV) outbreak in 2002 and the Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in 2012 …

FULL TEXT

https://www.nejm.org/doi/full/10.1056/NEJMp2000929?query=RP

PDF

https://www.nejm.org/doi/pdf/10.1056/NEJMp2000929?articleTools=true

Entry filed under: Biología Molecular, FIEBRE en el POST-VIAJE, Infecciones emergentes, Infecciones respiratorias, Infecciones virales, Medicina del viajero, Metodos diagnosticos, REPORTS, Sepsis, Update.

Brief Report – A Novel Coronavirus from Patients with Pneumonia in China, 2019 Candida auris Isolates Resistant to Three Classes of Antifungal Medications – New York, 2019.


Calendar

January 2020
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Most Recent Posts


%d bloggers like this: